0 items USD 0.00Search
Your search for "mrrpb5 global seasonal affective disorder treatment market size status forecast 2019 2025" gave back 1549437 results.
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Collagenase 3 - Pipeline Review, H1 2020 Summary Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Osteogenesis Imperfecta - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2019
Price: USD 2,000.00
Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Lipid Disorder Treatment market size was valued at US$ 3105.2 million in 2023. With growing demand in downstream market, the Lipid...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Pigmentation Disorder Treatment market size was valued at US$ 5930.1 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Thyroid Gland Disorders Treatment market size was valued at US$ 2885.8 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Autoimmune Disorders Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Autoimmune...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Osteogenesis Imperfecta - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
The global Bipolar Disorders and Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Bipolar...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Schizoaffective Disorders Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Osteogenesis Imperfecta (Genitourinary Disorders) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2021
Price: USD 2,000.00
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
